Market Overview

3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View

Share:
3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View
Related CL
Paws Up: The First Pets ETF Is Here
Jim Cramer Weighs In On Biogen, Colgate-Palmolive And More
Road To Financial Independence: Growing Dividends, Endless Opportunities But Limited Capital (Seeking Alpha)
Related CHD
Earnings Scheduled For November 1, 2018
Benzinga's Top Upgrades, Downgrades For August 7, 2018
The 'Other' A+ Companies: A Golden Ticket? - Part 2 (Seeking Alpha)

Colgate-Palmolive Company (NYSE: CL) CEO Ian Cook recently made headlines by saying he would accept a hypothetical buyout offer for the company of $100 per share. While there are no confirmed reports of buyout discussions ongoing, the quote now has traders speculating about which companies could be interested in a Colgate-Palmolive takeover.

Open an Ally Invest account and trade for as low as $3.95 per transaction.

3 Strong Contenders

The New York Post mentioned Unilever plc (ADR) (NYSE: UL), Johnson & Johnson (NYSE: JNJ) and Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B)/3G as potential suitors. Of the three names mentioned, Johnson & Johnson is the most likely buyer, Jefferies analyst Kevin Grundy said.

“We believe JNJ is the most likely suitor, at this juncture, as we are not of the view that ULVR is likely to make an approach right away following its recent strategic announcements,” Grundy said.

Related Link: Wall Street's M&A Chatter From May 17: SiriusXM-Pandora, WebMD, Colgate, Calpine

Rumors that either Johnson & Johnson or Unilever could be interested in buying Colgate-Palmolive have been around since at least 2011.

Looking At The Numbers

A buyout of Colgate-Palmolive would result in 13–18 percent EPS accretion for Unilever and 6–8 percent EPS accretion for Johnson & Johnson, Grundy said.

Still, the buyout rumors aren’t enough to make Colgate-Palmolive a buy.

“While we are favorably predisposed to high margin, high return businesses with attractive growth profiles and M&A optionality, we remain on the sidelines given the deterioration in Colgate’s topline trends and the uncertain outlook in EMs,” Grundy said.

Instead, Church & Dwight Co., Inc (NYSE: CHD) is the best option for investors looking to play potential consolidation in the cosmetics, household and personal care market, Grundy said.

Jefferies maintains a Hold rating and $76 price target for Colgate-Palmolive.

______
Image Credit: By Internet Archive Book Images [No restrictions],via Wikimedia Commons

Latest Ratings for CL

DateFirmActionFromTo
Oct 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Oct 2018ArgusMaintainsBuyBuy
Oct 2018SunTrust Robinson HumphreyDowngradesBuyHold

View More Analyst Ratings for CL
View the Latest Analyst Ratings

Posted-In: Ian Cook JefferiesAnalyst Color News Rumors Reiteration M&A Analyst Ratings Best of Benzinga

 

Related Articles (BRK-A + BRK-B)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
LXFTKeyBancDowngrades0.0
CPAImperial CapitalDowngrades68.0
PRMWImperial CapitalInitiates Coverage On18.0
TGTKeyBancInitiates Coverage On110.0
QCOMMorgan StanleyUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Jefferies Remains Bearish On L Brands Amid PINK's Slight Comp Positive, 'Far Off' Improving Trends

Cisco Hands In Solid Results, Weak Outlook In Q3 Report